Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02648282
What this trial is testing

Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 58
Not applicableLooking for participantsNCT06966440
What this trial is testing

Adjuvant Pancreatic Therapy Guided by MRD

Who this might be right for
Pancreatic Adenocarcinoma Resectable
Ruijin Hospital 856
Testing effectiveness (Phase 2)Study completedNCT00376948
What this trial is testing

Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Barbara Ann Karmanos Cancer Institute 20
Early research (Phase 1)Study completedNCT00063947
What this trial is testing

Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+1 more
National Cancer Institute (NCI) 28
Large-scale testing (Phase 3)UnknownNCT05149326
What this trial is testing

KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma.

Who this might be right for
Advanced Pancreatic Ductal Adenocarcinoma
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 408
Early research (Phase 1)Study completedNCT00655655
What this trial is testing

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+17 more
Mayo Clinic 96
Testing effectiveness (Phase 2)UnknownNCT03666832
What this trial is testing

Multi-center, Open-label, Phase 1b Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Who Have Failed First-Line Gemcitabine and Nab-Paclitaxel

Who this might be right for
Metastatic Pancreatic Cancer
Joon Oh Park 36
Post-approval studies (Phase 4)Looking for participantsNCT04373564
What this trial is testing

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Who this might be right for
Motor FunctionCognitive FunctionContrast Media
Guerbet 2,076
Testing effectiveness (Phase 2)Active Not RecruitingNCT06305247
What this trial is testing

Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours

Who this might be right for
MelanomaHead and Neck Squamous Cell CarcinomaPancreatic Ductal Adenocarcinoma+2 more
Ipsen 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175389
What this trial is testing

JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure

Who this might be right for
Refractory Pancreatic Ductal AdenocarcinomaRefractory Pancreatic Adenocarcinoma
West China Hospital 10
Not applicableStudy completedNCT03257150
What this trial is testing

The Use of Irreversible Electroporation in Pancreatic Ductal Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
University Health Network, Toronto 12
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT00012220
What this trial is testing

Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 259
Not applicableUnknownNCT04883450
What this trial is testing

PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Ductal Adenocarcinoma (PDAC)
Kaiser Permanente 126
Testing effectiveness (Phase 2)Ended earlyNCT02626520
What this trial is testing

Phase 2 Evaluation of Multi-modality Algorithm for Non-metastatic Adenocarcinoma of Pancreas or Ampulla

Who this might be right for
Ductal Adenocarcinoma of PancreasAdenocarcinoma of Ampulla
Essentia Health 11
Very early researchLooking for participantsNCT07089940
What this trial is testing

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+2 more
OHSU Knight Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT01580397
What this trial is testing

Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
ImmunityBio, Inc. 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05651022
What this trial is testing

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultHCC - Hepatocellular CarcinomaCRC (Colorectal Cancer)+5 more
Indaptus Therapeutics, Inc 120
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)UnknownNCT00010062
What this trial is testing

Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Next Page